187 related articles for article (PubMed ID: 19965953)
1. Influenza-associated cystic fibrosis pulmonary exacerbations.
Ortiz JR; Neuzil KM; Victor JC; Wald A; Aitken ML; Goss CH
Chest; 2010 Apr; 137(4):852-60. PubMed ID: 19965953
[TBL] [Abstract][Full Text] [Related]
2. Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.
Somayaji R; Goss CH; Khan U; Neradilek M; Neuzil KM; Ortiz JR
Clin Infect Dis; 2017 Jun; 64(12):1760-1767. PubMed ID: 28329304
[TBL] [Abstract][Full Text] [Related]
3. The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation.
Etherington C; Naseer R; Conway SP; Whitaker P; Denton M; Peckham DG
J Cyst Fibros; 2014 Jan; 13(1):49-55. PubMed ID: 23891398
[TBL] [Abstract][Full Text] [Related]
4. Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007.
Ortiz JR; Neuzil KM; Victor JC; Aitken ML; Goss CH
Chest; 2010 Dec; 138(6):1448-55. PubMed ID: 20495106
[TBL] [Abstract][Full Text] [Related]
5. Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis.
Flight WG; Bright-Thomas RJ; Tilston P; Mutton KJ; Guiver M; Morris J; Webb AK; Jones AM
Thorax; 2014 Mar; 69(3):247-53. PubMed ID: 24127019
[TBL] [Abstract][Full Text] [Related]
6. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.
O'Halloran AC; Holstein R; Cummings C; Daily Kirley P; Alden NB; Yousey-Hindes K; Anderson EJ; Ryan P; Kim S; Lynfield R; McMullen C; Bennett NM; Spina N; Billing LM; Sutton M; Schaffner W; Talbot HK; Price A; Fry AM; Reed C; Garg S
JAMA Netw Open; 2021 Aug; 4(8):e2121880. PubMed ID: 34427679
[TBL] [Abstract][Full Text] [Related]
7. Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis.
VanDevanter DR; Flume PA; Morris N; Konstan MW
J Cyst Fibros; 2016 Nov; 15(6):783-790. PubMed ID: 27139161
[TBL] [Abstract][Full Text] [Related]
8. Association between serum 25-hydroxyvitamin D level and pulmonary exacerbations in cystic fibrosis.
Vanstone MB; Egan ME; Zhang JH; Carpenter TO
Pediatr Pulmonol; 2015 May; 50(5):441-6. PubMed ID: 25657016
[TBL] [Abstract][Full Text] [Related]
9. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
10. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD;
JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
[TBL] [Abstract][Full Text] [Related]
12. Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States.
McGarry ME; Huang CY; Nielson DW; Ly NP
J Cyst Fibros; 2021 May; 20(3):424-431. PubMed ID: 33162303
[TBL] [Abstract][Full Text] [Related]
13. Influenza-Related Hospitalizations and Poverty Levels - United States, 2010-2012.
Hadler JL; Yousey-Hindes K; Pérez A; Anderson EJ; Bargsten M; Bohm SR; Hill M; Hogan B; Laidler M; Lindegren ML; Lung KL; Mermel E; Miller L; Morin C; Parker E; Zansky SM; Chaves SS
MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(5):101-5. PubMed ID: 26866729
[TBL] [Abstract][Full Text] [Related]
14. Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.
McGarry ME; Neuhaus JM; Nielson DW; Ly NP
Pediatr Pulmonol; 2019 Sep; 54(9):1382-1390. PubMed ID: 31144477
[TBL] [Abstract][Full Text] [Related]
15. Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis.
Viviani L; Assael BM; Kerem E;
J Cyst Fibros; 2011 Sep; 10(5):370-6. PubMed ID: 21752728
[TBL] [Abstract][Full Text] [Related]
16. Course of Illness after Viral Infection in Indian Children with Cystic Fibrosis.
Gulla KM; Balaji A; Mukherjee A; Jat KR; Sankar J; Lodha R; Kabra SK
J Trop Pediatr; 2019 Apr; 65(2):176-182. PubMed ID: 29893951
[TBL] [Abstract][Full Text] [Related]
17. Multivariate joint modeling to identify markers of growth and lung function decline that predict cystic fibrosis pulmonary exacerbation onset.
Andrinopoulou ER; Clancy JP; Szczesniak RD
BMC Pulm Med; 2020 May; 20(1):142. PubMed ID: 32429862
[TBL] [Abstract][Full Text] [Related]
18. Household transmission of influenza A(H1N1)pdm09 in the pandemic and post-pandemic seasons.
Casado I; Martínez-Baz I; Burgui R; Irisarri F; Arriazu M; Elía F; Navascués A; Ezpeleta C; Aldaz P; Castilla J;
PLoS One; 2014; 9(9):e108485. PubMed ID: 25254376
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical manifestations of cystic fibrosis in black and white patients.
Hamosh A; FitzSimmons SC; Macek M; Knowles MR; Rosenstein BJ; Cutting GR
J Pediatr; 1998 Feb; 132(2):255-9. PubMed ID: 9506637
[TBL] [Abstract][Full Text] [Related]
20. Oral antimicrobial use in outpatient cystic fibrosis pulmonary exacerbation management: a single-center experience.
Briggs EC; Nguyen T; Wall MA; MacDonald KD
Clin Respir J; 2012 Jan; 6(1):56-64. PubMed ID: 21595857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
